Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Operating Expenses | 2,667 | 3,300 | 510 | 660 | 318 |
| Operating Income | -2,667 | -3,300 | -510 | -660 | -318 |
| Interest Expense | 69 | 6,240 | 1,266 | 1,469 | 1,570 |
| Other Income | 14 | 20 | 0 | 1 | 0 |
| Pre-tax Income | -2,723 | -9,520 | -1,776 | -2,128 | -1,888 |
| Net Income Continuous | -2,723 | -9,520 | -1,776 | -2,128 | -1,888 |
| Net Income | $-2,723 | $-9,520 | $-1,776 | $-2,128 | $-1,888 |
| EPS Basic Total Ops | -22.81 | -704.68 | -238.30 | -285.71 | -252.10 |
| EPS Basic Continuous Ops | -22.86 | -702.86 | -238.52 | -285.73 | -253.46 |
| EPS Diluted Total Ops | -22.81 | -704.68 | -238.30 | -285.71 | -252.10 |
| EPS Diluted Continuous Ops | -22.86 | -702.86 | -238.52 | -285.73 | -253.46 |
| EBITDA(a) | $-2,666 | $-3,281 | $424 | $490 | $-91 |